Atlas Trials

Baricitinib Compared to Standard Therapy in Patients With COVID-19

Clinical trial NCT04393051 · UNKNOWN

Trial details

NCT number
NCT04393051
Sponsor
Azienda Ospedaliero, Universitaria Pisana
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Covid-19SARS-CoV 2SARS Pneumonia
Start date
2020-05-20
Primary completion
2020-06-30
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.